Circadian Rhythms and Sleep in Familial DSPS and ASPS

Sponsor
Northwestern University (Other)
Overall Status
Recruiting
CT.gov ID
NCT00246454
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
156
1
264
0.6

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the properties of circadian rhythms and sleep propensity in familial advanced and delayed sleep phase syndrome (DSPS).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    BACKGROUND:

    Tremendous progress in the past few years has led to the identification of several circadian clock genes. This now makes it possible to determine how alterations of human circadian clock genes and their expression could lead to differences in circadian and sleep/wake cycle phenotypes. Of particular interest for understanding genetics of the human circadian system are individuals with sleep phase disorders, such as DSPS and advanced sleep phase syndrome (ASPS), because recent studies indicate a genetic basis for these disorders. While it is assumed that both ASPS and DSPS are disorders of circadian timing, little is known about how the circadian clock system, or its interaction with sleep processes, are affected in these individuals.

    DESIGN NARRATIVE:

    Participants will complete questionnaires and actigraphy to determine sleep patterns and quality.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    156 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Circadian Rhythms and Sleep in Familial Delayed Sleep Phase Syndrome (DSPS) and Advanced Sleep Phase Syndrome (ASPS)
    Study Start Date :
    Sep 1, 2003
    Anticipated Primary Completion Date :
    Sep 1, 2025
    Anticipated Study Completion Date :
    Sep 1, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    1

    People with delayed sleep phase syndrome (DSPS).

    2

    People with advanced sleep phase syndrome (ASPS).

    3

    Control group (people with intermediate sleep patterns).

    Outcome Measures

    Primary Outcome Measures

    1. Sleep [1 night]

      Assessment of sleep parameters

    Secondary Outcome Measures

    1. Circadian Timing [3 days]

      Assessment of circadian activity profiles

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria for ASPS Participants:
    • Morning type score on the Horne-Ostberg questionnaire

    • Advanced melatonin onset

    Inclusion Criteria for DSPS Participants:
    • Evening type score on the Horne-Ostberg questionnaire

    • Delayed melatonin onset

    Inclusion Criteria for Controls:
    • A stable sleep/wake pattern with a normal phase relationship to the environment and no history of sleep disorders
    Exclusion Criteria for all subjects:
    • Sleep disorder, other than DSPS or ASPS, as assessed by the Pittsburgh Sleep Quality Index and/or by polysomnogram

    • History of cognitive or other neurological disorders

    • History of Diagnostic and Statistical Manual-IV criteria for any major psychiatric disorder, alcohol or substance abuse

    • Abnormal mood as assessed by the Hamilton Depression Scale

    • History of, or concurrent, unstable or serious medical illness

    • Current use of psychoactive medications, including antidepressants, anxiolytics, neuroleptics, anticonvulsants, hypnotics, and stimulant medications

    • Shift work

    • Having a daily caffeine intake greater than 4 cups per day

    • Smoking

    • Travel across more than 2 time zones within 90 days of the study

    • Pregnancy or the desire to become pregnant during the study period

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Northwestern University Chicago Illinois United States 60611

    Sponsors and Collaborators

    • Northwestern University
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Phyllis C. Zee, MD, PhD, Northwestern University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Phyllis Zee, Benjamin and Virginia T. Boshes Professor of Neurology, Northwestern University
    ClinicalTrials.gov Identifier:
    NCT00246454
    Other Study ID Numbers:
    • 341
    • R01HL069988
    First Posted:
    Oct 30, 2005
    Last Update Posted:
    May 5, 2021
    Last Verified:
    May 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Phyllis Zee, Benjamin and Virginia T. Boshes Professor of Neurology, Northwestern University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 5, 2021